These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36099961)

  • 1. Effects of N-terminal Acetylation on the Aggregation of Disease-related α-synuclein Variants.
    Bell R; Castellana-Cruz M; Nene A; Thrush RJ; Xu CK; Kumita JR; Vendruscolo M
    J Mol Biol; 2023 Jan; 435(1):167825. PubMed ID: 36099961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
    Lima VA; do Nascimento LA; Eliezer D; Follmer C
    ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein.
    Ruzafa D; Hernandez-Gomez YS; Bisello G; Broersen K; Morel B; Conejero-Lara F
    PLoS One; 2017; 12(5):e0178576. PubMed ID: 28562630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates.
    Bell R; Thrush RJ; Castellana-Cruz M; Oeller M; Staats R; Nene A; Flagmeier P; Xu CK; Satapathy S; Galvagnion C; Wilson MR; Dobson CM; Kumita JR; Vendruscolo M
    Biochemistry; 2022 Sep; 61(17):1743-1756. PubMed ID: 35944093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
    Mason RJ; Paskins AR; Dalton CF; Smith DP
    Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
    Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
    Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
    Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
    ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
    Watson MD; Lee JC
    Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the effects of N-terminal acetylation on α-synuclein structure, aggregation and cytotoxicity.
    Bell R; Vendruscolo M; Kumita JR
    Methods Enzymol; 2023; 686():45-65. PubMed ID: 37532408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
    Sanjeev A; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease-associated mutations in α-synuclein alters its lipid-bound state.
    Maltseva S; Kerr D; Turke M; Adams EJ; Lee KYC
    Biophys J; 2024 Jun; 123(12):1610-1619. PubMed ID: 38702883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillation of α-synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N-terminal acetylation and familial Parkinson's disease mutations.
    Monteiro Neto JR; Lima VA; Follmer C
    FEBS J; 2024 Mar; 291(6):1151-1167. PubMed ID: 38069536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein.
    Fauvet B; Fares MB; Samuel F; Dikiy I; Tandon A; Eliezer D; Lashuel HA
    J Biol Chem; 2012 Aug; 287(34):28243-62. PubMed ID: 22718772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity.
    Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M
    Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
    Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA
    Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of Cu
    Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
    Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.
    Kiely AP; Ling H; Asi YT; Kara E; Proukakis C; Schapira AH; Morris HR; Roberts HC; Lubbe S; Limousin P; Lewis PA; Lees AJ; Quinn N; Hardy J; Love S; Revesz T; Houlden H; Holton JL
    Mol Neurodegener; 2015 Aug; 10():41. PubMed ID: 26306801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.